57
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging

, , , , , , & show all
Pages 1819-1827 | Published online: 10 Dec 2015

References

  • EmeryAEThe muscular dystrophiesLancet200235968769511879882
  • JennekensFGten KateLPde VisserMWintzenARDiagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophyNeuromuscul Disord199113893911822350
  • ZatzMRapaportDVainzofMSerum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophyJ Neurol Sci19911021901962072118
  • VerhaertDRichardsKRafael-FortneyJARamanSVCardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerationsCirc Cardiovasc Imaging20114677621245364
  • FinstererJStollbergerCThe heart in human dystrophinopathiesCardiology20039911912589117
  • CoxGFKunkelLMDystrophies and heart diseaseCurr Opin Cardiol1997123293439243091
  • NaruseHMiyagiJAriiTOhyanagiMIwasakiTJinnaiKThe relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up studyAnn Nucl Med20041820320815233281
  • KumitaSChoKNakajoHClinical applications of ECG-gated myocardial perfusion SPECTJ Nippon Med Sch20067324825717106175
  • FuPHuLSinzingerJHuangJLiuXAssessment of cardiac abnormalities in Duchenne’s muscular dystrophy by (99m)Tc-MIBI gated myocardial perfusion imagingHell J Nucl Med20121511411922833857
  • SunYMaPBaxJJ99mTc-MIBI myocardial perfusion imaging in myocarditisNucl Med Commun20032477978312813196
  • BarkerSLeesDMWoodEGCorderRInhibitory effect of adrenomedullin on basal and tumour necrosis factor alpha-stimulated endothelin-1 synthesis in bovine aortic endothelial cells is independent of cyclic AMPBiochem Pharmacol20026314915611841788
  • MostellerRDSimplified calculation of body-surface areaN Engl J Med198731710983657876
  • CerqueiraMDWeissmanNJDilsizianVA statement for health-care professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart AssociationCirculation200210553954211815441
  • BermanDSHachamovitchRKiatHIncremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomographyJ Am Coll Cardiol1995266396477642853
  • RomfhAMcNallyEMCardiac assessment in duchenne and becker muscular dystrophiesCurr Heart Fail Rep2010721221820857240
  • CohnJNFerrariRSharpeNCardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac RemodelingJ Am Coll Cardiol20003556958210716457
  • NigroGComiLIPolitanoLBainRJThe incidence and evolution of cardiomyopathy in Duchenne muscular dystrophyInt J Cardiol1990262712772312196
  • SaitoMKawaiHAkaikeMAdachiKNishidaYSaitoSCardiac dysfunction with Becker muscular dystrophyAm Heart J19961326426478800037
  • NagamachiSInoueKJinnouchiSCardiac involvement of progressive muscular dystrophy (Becker type, Limb-girdle type and Fukuyama type) evaluated by radionuclide methodAnn Nucl Med1994871748204400
  • LapidosKAKakkarRMcNallyEMThe dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemmaCirc Res2004941023103115117830
  • ColanSDEvolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needsCirculation20051122756275816267247
  • KamogawaYBiroSMaedaMDystrophin-deficient myocardium is vulnerable to pressure overload in vivoCardiovasc Res20015050951511376626
  • PerloffJKHenzeESchelbertHRAlterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imagingCirculation19846933426605817
  • ErvastiJMSonnemannKJBiology of the striated muscle dystrophin-glycoprotein complexInt Rev Cytol200826519122518275889
  • JungCMartinsASNiggliEShirokovaNDystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathwaysCardiovasc Res20087776677318056762
  • TownsendDDalyMChamberlainJSMetzgerJMAge-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during agingMol Ther2011191821182521730971
  • CicconeMMNiccoli-AsabellaAScicchitanoPCardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery diseaseVasc Health Risk Manag2011712913421468172
  • MiuraPAndrewsMHolcikMJasminBJIRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cellsPLoS One20083e230918545658
  • St-PierreSJChakkalakalJVKolodziejczykSMKnudsonJCJasminBJMegeneyLAGlucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathwayFASEB J2004181937193915456738
  • BeenakkerEAFockJMVan TolMJIntermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trialArch Neurol20056212813215642859
  • ParreiraSLResendeMBZanoteliECarvalhoMSMarieSKReedUCComparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapyArq Neuropsiquiatr20106868368821049175
  • MarkhamLWKinnettKWongBLWoodrow BensonDCripeLHCorticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophyNeuromuscul Disord20081836537018436445